APOLLOHOSP.NS
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP.NS) is a major player in the healthcare industry with a market capitalization of ₹1,011.089 billion. It carries a high Price-to-Earnings (P/E) ratio of 97.22, which suggests that investors have high expectations for the company's future earnings growth despite its current stock price being on the high side relative to its earnings. This can be a positive indicator of future growth if the company meets or exceeds these expectations.
The company's Return on Equity (ROE) is not explicitly provided in the data but can be inferred to be impactful enough to sustain investor interest. However, the debt-to-equity ratio stands at 72.845, indicating that Apollo Hospitals relies on moderate leverage to finance its operations. This level of debt is manageable but indicates some level of financial risk if not controlled effectively.
Apollo Hospitals' operating margin of 9.786% highlights the company's profitability in its day-to-day operations, although there's room for improvement. The company’s earnings growth is quite robust at 83.2%, which is encouraging for potential investors who are seeking companies with strong growth trajectories. Complementing this, the revenue growth rate of 15.1% shows steady expansion, which could indicate successful strategic initiatives and market sustenance.
The EBITDA margin of 12.054% suggests a modest operating profit structure, which might appeal to those interested in stable investments. Moreover, the Price-to-Book ratio of 14.579 signals that the stock is potentially overvalued in terms of its book value, which could be a point of caution for value investors.
Institutional investors hold about 47.633% of the company's shares, demonstrating a significant level of confidence from substantial stakeholders. This could suggest stability and a positive outlook on the company's long-term performance from knowledgeable investors.
This overview of Apollo Hospitals offers prospective investors a comprehensive understanding of the company's financial landscape, emphasizing both lucrative prospects and potential areas of risk.
Last Updated: January 14, 2025
| Metric | Value |
|---|---|
| Market Cap | 964.34 B |
| P/E Ratio | 81.30 |
| ROE | 16.55 % |
| Debt to Equity | 93.132 |
| Operating Margin | 11.29 % |
| Free Cash Flow | 8.04 B |
| Institutional Holdings | 46.24 % |
| Revenue Growth | 15.30 % |
Apollo Hospitals' competitive landscape in the Indian healthcare sector:
- Multispecialty Hospitals: Fortis Healthcare and Max Healthcare are notable competitors.
- Standalone Specialty Hospitals: Manipal Hospitals and Narayana Health are notable competitors focusing on specialized services.
- Diagnostics and Pathology: Dr. Lal PathLabs and Thyrocare Technologies lead in the diagnostics field, competing with Apollo's diagnostic services.
- Health Insurance and Wellness Programs: Star Health and Allied Insurance Co. Ltd and ICICI Lombard offer competitive health insurance solutions that align with hospital services.
Apollo Hospitals remains a forefront leader in the Indian healthcare sector due to its expansive hospital network, comprehensive range of services, and focus on quality care. However, with a dynamic and competitive landscape, Apollo faces challenges from other healthcare providers and diagnostic services. For potential investors, the key considerations include Apollo's potential for growth, its expansion strategies, and how it innovatively incorporates technology and integrated services to maintain its competitive edge in the industry.
Disclaimer: The information provided here is for educational and informational purposes only. While we strive to ensure the accuracy and reliability of the data, we do not make any guarantees regarding its completeness or accuracy. The analysis and metrics provided should not be considered as investment advice, and any actions taken based on this information are at your own risk. We do not assume responsibility for any financial losses or other damages incurred from the use of this data. Please consult with a qualified financial advisor before making any investment decisions.